<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00214747</url>
  </required_header>
  <id_info>
    <org_study_id>RRU-003</org_study_id>
    <nct_id>NCT00214747</nct_id>
  </id_info>
  <brief_title>An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina</brief_title>
  <official_title>An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina: Candidate Formulations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biosyn</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Biosyn</source>
  <brief_summary>
    <textblock>
      This study is designed to assess the distribution and spread of four different vehicle
      formulations in the vagina. In-vivo data will be obtained regarding each vehicle formulation
      at various time points after insertion of the gel into the vagina.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2005</start_date>
  <completion_date>November 2005</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MRI evaluation of gel formulation distribution in vagina</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Total linear distance in mm covered by gel</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Surface area actually covered by gel (mm)</measure>
  </primary_outcome>
  <enrollment>6</enrollment>
  <condition>HIV Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vehicle gel formulations</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 45 year old women

          -  non-pregnant

          -  healthy

        Exclusion Criteria:

          -  abnormal finding on pelvic exam

          -  pregnant or breastfeeding

          -  allergy to intravaginal products

          -  history of claustrophobia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kurt Barnhart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rreproductive Research Unit, U of Penn Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>October 24, 2005</last_update_submitted>
  <last_update_submitted_qc>October 24, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2005</last_update_posted>
  <keyword>HIV Seronegativity</keyword>
  <keyword>HIV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

